Related Experiment Video
Updated: Jun 16, 2025

Cardiac Magnetic Resonance Imaging at 7 Tesla
Published on: January 6, 2019
Cardiac Manifestations of Hemochromatosis
Priyanka Gera1, Vitor De Oliveira, William H Frishman
1From the Departments of Cardiology and Medicine, New York Medical College, Westchester Medical Center, Valhalla, NY.
Insights
Cardiac hemochromatosis, caused by iron overload, leads to heart failure. Early diagnosis and treatment, including phlebotomy or chelation therapy, are crucial for improving patient survival and managing this condition.
Area of Science:
- Cardiology
- Hematology
- Genetics
Background:
- Cardiac hemochromatosis results from iron overload, causing cardiomyopathy and heart failure.
- It can stem from primary (genetic) or secondary (acquired) iron-related disorders.
- Iron dysregulation is the key mechanism leading to cardiotoxicity.
Purpose of the Study:
- To comprehensively review cardiac hemochromatosis.
- To elucidate its pathophysiology, clinical presentation, diagnosis, and management.
- To highlight the importance of timely intervention for patient survival.
Main Methods:
- Literature review compiling information on cardiac hemochromatosis.
- Discussion of diagnostic tools: biochemical markers, ECG, echocardiography, MRI.
- Analysis of current and potential treatment strategies.
Main Results:
- Cardiac hemochromatosis presents diagnostic challenges but is manageable with appropriate tools.
- Phlebotomy is standard treatment; chelation therapy is an alternative for specific patients.
- Emerging therapies require further research for cardiac benefits.
Conclusions:
- Early screening and intervention are vital for mitigating morbidity and mortality.
- Timely management of cardiac hemochromatosis can significantly improve patient prognosis.
- Further research into novel therapies is needed to enhance cardiac function outcomes.
Abstract:
Cardiac hemochromatosis, a consequence of primary or secondary iron-overload conditions, poses a threat to patient health, leading to cardiomyopathy and heart failure. This review aims to compile comprehensive information on cardiac hemochromatosis, elucidating its pathophysiology, clinical presentation, diagnosis, and management strategies. Primary and secondary hemochromatosis, genetic and acquired forms, can result in cardiotoxicity by means of iron dysregulation. Diagnostic tools, including biochemical markers, electrocardiography, echocardiography, and magnetic resonance imaging (MRI), are utilized for early detection as well as long-term monitoring post-treatment. For treatment options, phlebotomy is the standard, but for some patients (such as those with anemia), chelation therapy is an alternative option. Other potential therapies include erythrocytapheresis, calcium channel blockers, and hepcidin-targeted approaches, for which more research is needed to understand cardiac function benefits. With the onset of cardiac symptoms, patient health rapidly deteriorates. Thus, timely intervention to mitigate associated morbidity and mortality by means of screening can promote and prolong patient survival.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Pathophysiology of Heart Failure
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Mechanism of Cardiac Arrhythmias

